Literature DB >> 22585450

Effects of Crataegus microphylla on vascular dysfunction in streptozotocin-induced diabetic rats.

Gökçe Topal1, Ebru Koç, Cetin Karaca, Tuncay Altuğ, Bülent Ergin, Cihan Demirci, Gülay Melikoğlu, Ali H Meriçli, Mine Kucur, Osman Ozdemir, B Sönmez Uydeş Doğan.   

Abstract

Vascular dysfunction plays a key role in the pathogenesis of diabetic vascular disease. In this study, we aimed to investigate whether chronic in vivo treatment of Crataegus microphylla (CM) extract in diabetic rats induced with streptozotocin (STZ, intraperitoneal, 65 mg/kg) preserves vascular function and to evaluate whether the reduction of inducible nitric oxide synthase (iNOS), proinflammatory cytokines, and lipid peroxidation mediates its mechanisms of action. Starting at 4 weeks of diabetes, CM extract (100 mg/kg) was administrated to diabetic rats for 4 weeks. In aortic rings, relaxation to acetylcholine and vasoreactivity to noradrenaline were impaired, whereas aortic iNOS expression and plasma tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), total nitrite-nitrate, and malondialdehite levels were increased in diabetic rats compared with controls. Chronic CM treatment significantly corrected all the above abnormalities in diabetic rats. In comparison, pretreatment of the aorta of diabetic rats with N-[3(aminomethyl) benzyl]-acetamidine, dihydrochloride (10(-5)  M), a selective inhibitor of iNOS, produced a similar recovery in vascular reactivity. These results suggest that chronic in vivo treatment of CM preserves endothelium-dependent relaxation and vascular contraction in STZ-induced diabetes, possibly by reducing iNOS expression in the aorta and by decreasing plasma levels of TNF-α and IL-6 and by preventing lipid peroxidation.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585450     DOI: 10.1002/ptr.4726

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Inhibitory Effects of Saururus chinensis Extract on Receptor for Advanced Glycation End-Products-Dependent Inflammation and Diabetes-Induced Dysregulation of Vasodilation.

Authors:  Kenjiro Hayashi; Koichi Sato; Seishi Ochi; Shuhei Kawano; Seiichi Munesue; Ai Harashima; Yu Oshima; Kumi Kimura; Takashi Kyoi; Yasuhiko Yamamoto
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 2.  Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-29       Impact factor: 2.629

3.  Antihypertensive Effects of Hydroalcoholic Extract of Crataegus Azarolus Subspecies Aronia Fruit in Rats with Renovascular Hypertension: An Experimental Mechanistic Study.

Authors:  Mohammad Reza Haydari; Mohammad Reza Panjeshahin; Elaheh Mashghoolozekr; Ali Akbar Nekooeian
Journal:  Iran J Med Sci       Date:  2017-05

4.  Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats.

Authors:  Hayrullah Alp; Burak Cem Soner; Tamer Baysal; Ayşe Saide Şahin
Journal:  Anatol J Cardiol       Date:  2014-12-25       Impact factor: 1.596

5.  Hawthorn Fruit Extract Elevates Expression of Nrf2/HO-1 and Improves Lipid Profiles in Ovariectomized Rats.

Authors:  Jeong-Hyun Yoo; Yanan Liu; Hyun-Sook Kim
Journal:  Nutrients       Date:  2016-05-13       Impact factor: 5.717

Review 6.  Anti-hypertensive Herbs and their Mechanisms of Action: Part I.

Authors:  Sara S Al Disi; M Akhtar Anwar; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-01-19       Impact factor: 5.810

Review 7.  Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review.

Authors:  Min Wu; Longtao Liu; Yanwei Xing; Shengjie Yang; Hao Li; Yu Cao
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

Review 8.  Plants Used as Antihypertensive.

Authors:  Tarawanti Verma; Manish Sinha; Nitin Bansal; Shyam Raj Yadav; Kamal Shah; Nagendra Singh Chauhan
Journal:  Nat Prod Bioprospect       Date:  2020-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.